Skip to main content

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

02 Feb 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended December 2022, as compared to corresponding quarter of last year.The Net Profit of the company reported a remarkable increase of 2636.36% to Rs. 3.01  millions  from Rs. 0.11 millions in previous same quarter.Operating profit surged to 3.01 millions from the corresponding previous quarter of 0.11 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 -15.37 24.75 -162.10 21.62 0.15 14313.33
Other Income 3.25 0.29 1020.69 23.75 -1.35 -1859.26 0.07 0.00 0.00
PBIDT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 3.01 0.11 2636.36 6.52 2.23 192.38 -0.08 -16.03 -99.50
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 -42.42 9.01 -570.81 -0.37 -10686.67 -100.00
Peers
Company Name CMP
Redington 349.60
Adani Enterprises 2682.00
Amrapali Industries 32.78
Maxgrow India 174.80
Rashi Peripheral 689.15
View more..